• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: PD

One-third of early PD patients show cognitive decline

October 20, 2009  

Differentiating subtypes of dementia in Parkinson’s disease

August 25, 2009  

Response to levodopa: long-term follow-up

August 25, 2009  

The effects of stress in Parkinson’’s disease

August 25, 2009  

Risk of Parkinson’s disease with cumulative lead exposure

July 7, 2009  

Estimating duration of work ability with motor symptom onset

June 22, 2009  

Predicting depression in early Parkinson’s disease

June 9, 2009  

Estimating the lifetime risk of PD

May 5, 2009  

Parkinson motor score higher with suboptimal adherence

April 21, 2009  

Nortriptyline effective in PD-associated depression

April 7, 2009  
Previous
5
6
7
8
Next

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • AES 2025 (1)
  • EPILEPSY (38)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Anti-CD20 therapy in MS: comparing efficacy and safety posted on July 21, 2026
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Highlights of EAN 2026 – Part 1 posted on June 30, 2026
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions